We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Halts Development of Investigational Drugs Zalbin, Mycograb
The item has been added to your shopping cart.
Novartis Halts Development of Investigational Drugs Zalbin, Mycograb
October 5, 2010
Novartis has pulled the plug on two of its investigational drug candidates, including the hepatitis C drug Zalbin.